Form 4: Insmed Inc. COO Roger Adsett Sells Shares Under 10b5-1 Trading Plan

Insmed Inc.'s Chief Operating Officer, Roger Adsett, sold 1,457 shares of common stock at $68.72 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Roger Adsett, the Chief Operating Officer of Insmed Inc., sold 1,457 shares of the company's common stock.
• The sale occurred on January 14, 2025, at a price of $68.72 per share.
• This transaction was executed under a pre-established 10b5-1 trading plan.
• Following the transaction, Adsett directly owns 146,082 shares of Insmed Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding a stock sale by an executive under a pre-arranged plan. It doesn't indicate any significant positive or negative sentiment.

Risks

• Sales by company executives can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to sell shares to avoid accusations of insider trading.

Comparison to Industry Standards

• Sales by executives are a common occurrence in publicly traded companies.
• The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
• The volume of shares sold is relatively small compared to the total outstanding shares of Insmed Inc.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

Keywords

Insmed Inc, Roger Adsett, Chief Operating Officer, stock sale, 10b5-1 trading plan, insider trading, share transaction